KRAS and cancer: These findings suggest that the dysregulation of cancer-related pathways, such as KRAS and IL6-JAK-STAT3, plays a critical role not only in tumor microenvironment remodeling but also in the pathological processes of AS, such as SMC transdifferentiation and plaque progression.